etoposide has been researched along with maytansine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Adamson, RH; Mead, JA; Sieber, SM | 1 |
| Botkin, C; Knutsen, T; Sieber, SM; Whang-Peng, J | 1 |
| Yalowich, JC | 1 |
| Iida, H; Ohkochi, E; Sakurai, Y; Tsukagoshi, S; Tsuruo, T | 1 |
| Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M | 1 |
| Kim, JO; Kim, KH; Park, JY; Park, SG; Seo, MD | 1 |
1 review(s) available for etoposide and maytansine
| Article | Year |
|---|---|
Pharmacology of antitumor agents from higher plants.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aporphines; Camptothecin; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Etoposide; Humans; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Maytansine; Melanoma; Naphthoquinones; Nasopharyngeal Neoplasms; Neoplasms; Neoplasms, Experimental; Phenanthrenes; Structure-Activity Relationship; Teniposide; Vinblastine; Vincristine | 1976 |
6 other study(ies) available for etoposide and maytansine
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Cells, Cultured; Chromosome Aberrations; Chromosomes; Colchicine; Etoposide; Female; Gestational Age; Maytansine; Mice; Pregnancy; Teniposide; Teratogens; Vincristine | 1978 |
Effects of microtubule inhibitors on etoposide accumulation and DNA damage in human K562 cells in vitro.
Topics: Alkaloids; Cell Line; Colchicine; DNA; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; In Vitro Techniques; Maytansine; Microtubules; Paclitaxel; Podophyllotoxin; Time Factors; Vinblastine | 1987 |
Establishment and properties of vincristine-resistant human myelogenous leukemia K562.
Topics: Cell Line; Cells, Cultured; Clone Cells; Doxorubicin; Drug Resistance; Etoposide; Humans; Leukemia, Myeloid; Maytansine; Vincristine | 1983 |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines | 1982 |
Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer.
Topics: Animals; Antibodies, Monoclonal, Humanized; Carboplatin; Cell Line, Tumor; Cell Proliferation; Etoposide; Female; Humans; Immunoconjugates; Lung Neoplasms; Maytansine; Mice; Proto-Oncogene Proteins c-kit; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Small Cell Lung Carcinoma; Trastuzumab; Tubulin Modulators; Xenograft Model Antitumor Assays | 2022 |